These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 10935349

  • 1. Treatment of pyoderma gangrenosum with oral Tripterygium wilfordii multiglycoside.
    Li LF.
    J Dermatol; 2000 Jul; 27(7):478-81. PubMed ID: 10935349
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effect of Tripterygium wilfordii multiglycoside on increased glomerular albumin permeability in vitro.
    Sharma M, Li JZ, Sharma R, Artero M, Ge X, McCarthy ET, Wang HY, Savin V.
    Nephrol Dial Transplant; 1997 Oct; 12(10):2064-8. PubMed ID: 9351066
    [Abstract] [Full Text] [Related]

  • 3. Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy.
    Shang SL, Cai GY, Duan SW, Li P, Li QG, Chen XM.
    BMC Nephrol; 2018 Jul 18; 19(1):182. PubMed ID: 30021637
    [Abstract] [Full Text] [Related]

  • 4. Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study.
    Liu S, Li X, Li H, Liang Q, Chen J, Chen J.
    BMC Nephrol; 2015 Dec 04; 16():200. PubMed ID: 26637482
    [Abstract] [Full Text] [Related]

  • 5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D.
    Acta Dermatovenerol Croat; 2016 Apr 04; 24(1):83-5. PubMed ID: 27149138
    [Abstract] [Full Text] [Related]

  • 6. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.
    Li J, Kelly R.
    J Am Acad Dermatol; 2013 Oct 04; 69(4):565-9. PubMed ID: 23850090
    [Abstract] [Full Text] [Related]

  • 7. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f.
    Qiu D, Kao PN.
    Drugs R D; 2003 Oct 04; 4(1):1-18. PubMed ID: 12568630
    [Abstract] [Full Text] [Related]

  • 8. Toxicogenomic analysis of the gene expression changes in rat liver after a 28-day oral Tripterygium wilfordii multiglycoside exposure.
    Zhang Y, Jiang Z, Xue M, Zhang S, Wang Y, Zhang L.
    J Ethnopharmacol; 2012 May 07; 141(1):170-7. PubMed ID: 22366672
    [Abstract] [Full Text] [Related]

  • 9. [Extensive ulcerations in children: The difficulty diagnosing pyoderma gangrenosum].
    Ramli I, Rachadi H, Amarouch H, Rimani M, Senouci K, Benzekri L, Hassam B.
    Arch Pediatr; 2015 Jul 07; 22(7):753-5. PubMed ID: 26047747
    [Abstract] [Full Text] [Related]

  • 10. Mechanism for the therapeutic effect of Tripterygium wilfordii Hook. f. preparations on IgA nephropathy.
    Zhao J, Liu H.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May 28; 47(5):573-582. PubMed ID: 35753727
    [Abstract] [Full Text] [Related]

  • 11. Tripterygium wilfordii glycosides ameliorates collagen-induced arthritis and aberrant lipid metabolism in rats.
    Zhu Y, Zhang L, Zhang X, Wu D, Chen L, Hu C, Wen C, Zhou J.
    Front Pharmacol; 2022 May 28; 13():938849. PubMed ID: 36105231
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effects of Tripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats.
    Shen HN, Xu Y, Jiang ZZ, Huang X, Zhang LY, Wang T.
    Chin J Nat Med; 2015 Jun 28; 13(6):421-7. PubMed ID: 26073338
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tripterygium wilfordii Glycosides Upregulate the New Anti-Inflammatory Cytokine IL-37 through ERK1/2 and p38 MAPK Signal Pathways.
    Wang S, Li R, He S, He L, Zhao H, Deng X, Chen Z.
    Evid Based Complement Alternat Med; 2017 Jun 28; 2017():9148523. PubMed ID: 29403538
    [Abstract] [Full Text] [Related]

  • 16. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.
    Tao X, Cush JJ, Garret M, Lipsky PE.
    J Rheumatol; 2001 Oct 28; 28(10):2160-7. PubMed ID: 11669150
    [Abstract] [Full Text] [Related]

  • 17. Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.
    Sakamoto T, Hashimoto T, Furukawa F.
    Eur J Dermatol; 2002 Oct 28; 12(5):485-7. PubMed ID: 12370142
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of Systemic Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Review.
    Din RS, Tsiaras WG, Li DG, Mostaghimi A.
    J Drugs Dermatol; 2018 Oct 01; 17(10):1058-1060. PubMed ID: 30365585
    [Abstract] [Full Text] [Related]

  • 19. Beneficial Modulation of Lipid Mediator Biosynthesis in Innate Immune Cells by Antirheumatic Tripterygium wilfordii Glycosides.
    Zhang K, Pace S, Jordan PM, Peltner LK, Weber A, Fischer D, Hofstetter RK, Chen X, Werz O.
    Biomolecules; 2021 May 17; 11(5):. PubMed ID: 34067705
    [Abstract] [Full Text] [Related]

  • 20. Resolution of severe lupus nephritis associated with Tripterygium wilfordii hook F ingestion.
    Kao NL, Richmond GW, Moy JN.
    Arthritis Rheum; 1993 Dec 17; 36(12):1751-2. PubMed ID: 8250996
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.